Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
354
-
Total 13F shares, excl. options
-
53.9M
-
Shares change
-
-366K
-
Total reported value, excl. options
-
$7.61B
-
Value change
-
-$43.5M
-
Put/Call ratio
-
1.4
-
Number of buys
-
195
-
Number of sells
-
-152
-
Price
-
$141.31
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2016
426 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2016.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 354 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.9M shares
.
Largest 10 shareholders include FMR LLC (8.8M shares), PUTNAM INVESTMENTS LLC (8.04M shares), VANGUARD GROUP INC (4.22M shares), FIL Ltd (1.8M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.78M shares), Bank of New York Mellon Corp (1.23M shares), BlackRock Institutional Trust Company, N.A. (1.06M shares), BlackRock Fund Advisors (999K shares), JANUS CAPITAL MANAGEMENT LLC (993K shares), and JPMORGAN CHASE & CO (833K shares).
This table shows the top 354 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.